These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22589088)

  • 1. microRNA dysregulation in prostate cancer: network analysis reveals preferential regulation of highly connected nodes.
    Budd WT; Weaver DE; Anderson J; Zehner ZE
    Chem Biodivers; 2012 May; 9(5):857-67. PubMed ID: 22589088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.
    Alshalalfa M; Bader GD; Bismar TA; Alhajj R
    PLoS One; 2013; 8(12):e84261. PubMed ID: 24391925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in prostate cancer: From function to biomarker discovery.
    Moustafa AA; Kim H; Albeltagy RS; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2018 Jun; 243(10):817-825. PubMed ID: 29932371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritizing candidate disease miRNAs by topological features in the miRNA target-dysregulated network: case study of prostate cancer.
    Xu J; Li CX; Lv JY; Li YS; Xiao Y; Shao TT; Huo X; Li X; Zou Y; Han QL; Li X; Wang LH; Ren H
    Mol Cancer Ther; 2011 Oct; 10(10):1857-66. PubMed ID: 21768329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
    Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
    Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
    Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
    Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting microRNAs of high influence on protein functional interaction networks: a prostate cancer case study.
    Alshalalfa M; Bader GD; Goldenberg A; Morris Q; Alhajj R
    BMC Syst Biol; 2012 Aug; 6():112. PubMed ID: 22929553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
    Wilk G; Braun R
    Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A networks method for ranking microRNA dysregulation in cancer.
    Budd WT; Seashols S; Weaver D; Joseph C; Zehner ZE
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S3. PubMed ID: 24564923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread deregulation of microRNA expression in human prostate cancer.
    Ozen M; Creighton CJ; Ozdemir M; Ittmann M
    Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
    Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
    Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
    Noonan EJ; Place RF; Basak S; Pookot D; Li LC
    Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA in prostate cancer.
    Khanmi K; Ignacimuthu S; Paulraj MG
    Clin Chim Acta; 2015 Dec; 451(Pt B):154-60. PubMed ID: 26415820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.
    Sidorova EA; Zhernov YV; Antsupova MA; Khadzhieva KR; Izmailova AA; Kraskevich DA; Belova EV; Simanovsky AA; Shcherbakov DV; Zabroda NN; Mitrokhin OV
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
    Gordanpour A; Nam RK; Sugar L; Bacopulos S; Seth A
    J Vis Exp; 2012 May; (63):e3874. PubMed ID: 22643910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma.
    Dankert JT; Wiesehöfer M; Wach S; Czyrnik ED; Wennemuth G
    Sci Rep; 2020 Oct; 10(1):18022. PubMed ID: 33093529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
    Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
    Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
    Ghafouri-Fard S; Shoorei H; Taheri M
    Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.